Disseminated BCG Infection after intravesical BCG Immunotherapy of Bladder Cancer
QJM
.
2021 Oct 7;114(6):410-411.
doi: 10.1093/qjmed/hcab033.
Authors
S Ramalingam
,
K Gunasekaran
1
,
H Arora
,
M Muruganandam
2
,
S Nagaraju
,
P Padmanabhan
3
Affiliations
1
Department of Pulmonary and Critical Care, Pulmonary and Critical Care, Bridgeport Hospital, 267 Grant Street, Bridgeport, CT 06610-5000, USA.
2
Department of Rheumatology, University of New Mexico, 2211 Lomas Blvd NE, Albuquerque, NM 87106, USA.
3
Department of Cardiology, Unity Point Cardiology, 1301 Pennsylvania Ave Ste 100, Des Moines, IA 50316, USA.
PMID:
33585923
DOI:
10.1093/qjmed/hcab033
No abstract available
MeSH terms
BCG Vaccine / adverse effects
Humans
Immunotherapy / adverse effects
Rare Diseases
Tuberculosis*
Urinary Bladder Neoplasms* / drug therapy
Substances
BCG Vaccine